Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 217 Neoplasms 196 Carcinoma, Non-Small-Cell Lung 94 Colorectal Neoplasms 92 Prostatic Neoplasms 79 Lung Neoplasms 74 Multiple Myeloma 49 Head and Neck Neoplasms 48 Neoplasm Metastasis 46 Melanoma 46 Pancreatic Neoplasms 44 Leukemia, Myeloid, Acute 41 Carcinoma, Hepatocellular 41 Recurrence 35 Brain Neoplasms 35 Squamous Cell Carcinoma of Head and Neck 34 Ovarian Neoplasms 32 Glioblastoma 30 Uterine Cervical Neoplasms 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Sarcoma 27 Glioma 27 Lymphoma, Non-Hodgkin 26 Lymphoma 26 Stomach Neoplasms 25 Carcinoma, Renal Cell 25 Lymphoma, Follicular 24 Colonic Neoplasms 24 Motor Activity 22 Esophageal Neoplasms 22

Interventions

atezolizumab 1 Radiotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Locally Advanced Cervical Cancer × 90 days × Clear all

NCT03612791 2026-04-03

ATEZOLACC

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Completed

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡